ARS Pharmaceuticals Inc (SPRY)
8.66
-0.28
(-3.13%)
USD |
NASDAQ |
Jun 14, 16:00
8.64
-0.02
(-0.23%)
After-Hours: 20:00
ARS Pharmaceuticals Total Assets (Quarterly): 227.58M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 227.58M |
| December 31, 2023 | 233.19M |
| September 30, 2023 | 248.56M |
| June 30, 2023 | 258.75M |
| Date | Value |
|---|---|
| March 31, 2023 | 271.19M |
| December 31, 2022 | 281.44M |
| June 30, 2022 | 46.05M |
| December 31, 2021 | 61.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
46.05M
Minimum
Jun 2022
281.44M
Maximum
Dec 2022
203.53M
Average
240.87M
Median
Total Assets (Quarterly) Benchmarks
| KalVista Pharmaceuticals Inc | 113.97M |
| Phathom Pharmaceuticals Inc | 356.50M |
| Vera Therapeutics Inc | 419.36M |
| Nuvalent Inc | 708.47M |
| CEL-SCI Corp | 30.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.715M |
| Shareholders Equity (Quarterly) | 223.87M |